塞力医疗
(603716)
| 流通市值：54.88亿 | | | 总市值：54.88亿 |
| 流通股本：2.10亿 | | | 总股本：2.10亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 583,500,840.55 | 287,429,208.68 | 1,810,681,362.15 | 1,420,111,454.42 |
| 营业收入 | 583,500,840.55 | 287,429,208.68 | 1,810,681,362.15 | 1,420,111,454.42 |
| 二、营业总成本 | 631,911,725.44 | 309,686,560.92 | 1,891,348,685.68 | 1,444,210,701.93 |
| 营业成本 | 452,874,288.96 | 219,586,699.65 | 1,478,798,942.33 | 1,137,695,865.9 |
| 税金及附加 | 2,835,349.21 | 1,529,356.25 | 8,222,328.95 | 5,425,670.16 |
| 销售费用 | 47,023,885.66 | 24,063,391.05 | 127,591,199.13 | 100,018,355.49 |
| 管理费用 | 77,571,698.48 | 38,615,676.45 | 174,918,945.83 | 122,836,376.29 |
| 研发费用 | 24,527,034.96 | 13,980,853.82 | 46,742,915.06 | 31,457,970.43 |
| 财务费用 | 27,079,468.17 | 11,910,583.7 | 55,074,354.38 | 46,776,463.66 |
| 其中:利息费用 | 27,234,161.7 | 11,804,733.65 | 57,681,022.85 | 50,580,751.84 |
| 其中:利息收入 | 549,733.22 | 364,360.32 | 3,838,688.09 | 5,951,084.51 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 9,736,549.95 | 11,670,780.29 | -65,216,566.55 | -47,577,734.26 |
| 资产处置收益 | 835,879.46 | 757,346.65 | -7,620,084.92 | 281,262.2 |
| 资产减值损失(新) | -372,558.04 | -80,168.05 | -25,597,401.25 | -465,161.42 |
| 信用减值损失(新) | -14,002,932.83 | -1,792,894.56 | 34,605,768.01 | 19,536,326 |
| 其他收益 | 952,316.55 | 254,413.66 | 2,701,532.6 | 2,140,735.08 |
| 四、营业利润 | -51,261,629.8 | -11,447,874.25 | -141,794,075.64 | -50,183,819.91 |
| 加:营业外收入 | 72,326.36 | 107,542.15 | 1,383,928.08 | 1,428,624.25 |
| 减:营业外支出 | 736,808.08 | 83,782.29 | 7,886,710.8 | 1,539,192.52 |
| 五、利润总额 | -51,926,111.52 | -11,424,114.39 | -148,296,858.36 | -50,294,388.18 |
| 减:所得税费用 | -372,487.66 | 341,554.85 | 45,092,718.78 | -16,781,741.35 |
| 六、净利润 | -51,553,623.86 | -11,765,669.24 | -193,389,577.14 | -33,512,646.83 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -51,553,623.86 | -11,765,669.24 | -193,389,577.14 | -33,512,646.83 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -56,119,215.09 | -14,320,949.69 | -209,239,667.57 | -56,025,062.27 |
| 少数股东损益 | 4,565,591.23 | 2,555,280.45 | 15,850,090.43 | 22,512,415.44 |
| 扣除非经常损益后的净利润 | -70,597,925.09 | -28,463,262.68 | -135,080,338.31 | -26,111,732.56 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.29 | -0.07 | -1.09 | -0.28 |
| (二)稀释每股收益 | -0.29 | -0.07 | -1.09 | -0.28 |
| 八、其他综合收益 | -700,021.85 | -53,613.64 | 6,075,434.7 | -10,669,820.47 |
| 归属于母公司股东的其他综合收益 | -700,021.85 | -53,613.64 | 6,075,434.7 | -10,669,820.47 |
| 九、综合收益总额 | -52,253,645.71 | -11,819,282.88 | -187,314,142.44 | -44,182,467.3 |
| 归属于母公司股东的综合收益总额 | -56,819,236.94 | -14,374,563.33 | -203,164,232.87 | -66,694,882.74 |
| 归属于少数股东的综合收益总额 | 4,565,591.23 | 2,555,280.45 | 15,850,090.43 | 22,512,415.44 |
| 公告日期 | 2025-08-29 | 2025-04-29 | 2025-04-29 | 2024-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |